Top Markets
Coin of the day
Ascendis Health Limited Ascendis Health Limited

Ascendis Health Limited

ASC
주식 순위 #39753
Ascendis Health Limited is a health and wellness enterprise that manufactures... Ascendis Health Limited is a health and wellness enterprise that manufactures and distributes healthcare products across South Africa, Cyprus, Spain, Hungary, Romania, and other international markets. The company's operations are divided into three key segments: Consumer Health, Pharma, and Medical. Within its Consumer Health portfolio, it offers a variety of body and skin care items, alongside numerous supplements such as natural, multi-vitamin, mineral, micronutrient, and nutraceutical options, as well as homeopathic and herbal remedies, marketed under brands like Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce. The Medical segment provides essential medical devices, diagnostic laboratory equipment, and related consumables for diverse settings, including operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, and scientific research institutes. Concurrently, the Pharma division offers a wide array of generic pharmaceutical products, encompassing antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives, and treatments targeting the nervous and cardiovascular systems, dermatological issues, and antimalarial conditions, among other therapeutic solutions. These medical and pharmaceutical products are distributed under brands such as Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group. Ascendis Health also exports its products and serves a broad customer base including pharmacies, retailers, beauticians, and doctors. The company was founded in 2008 and is headquartered in Johannesburg, South Africa.
주가
$0.05742053
마지막 동기화: 2025-11-28
시가총액
$359.48K
변동 (1일)
7.05%
변동 (1년)
21.86%
국가
ZA
거래 Ascendis Health Limited (ASC)

카테고리

Ascendis Health Limited (ASC)의 P/E 비율
2026 기준 P/E 비율 TTM: 0
Ascendis Health Limited의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 0입니다. 2026년 말 기준 P/E 비율은 0였습니다.
Ascendis Health Limited의 P/E 비율 기록 (2026 ~ 2026)
매년 말 P/E 비율
연도 P/E 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/E 비율
P/E 비율 읽는 방법

P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.

P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.

양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.